Lupin is comprised of a fast growing, innovative and robust team of manufacturing, Research and Development and commercial divisions. Together these entities make up the generic and branded U.S. business. Lupin has a significant generic pipeline, and a branded focus on women’s health. Our first Research and Development facility in the US is located in Coral Springs, Florida which focuses on generic and branded orally inhaled and nasal drug products. Somerset, New Jersey is home to one of twelve commercial manufacturing sites globally and the only commercial manufacturing facility in the United States for Lupin, as well as additional Research and Development teams. Lupin is prided on being people-focused and centered around how impactful we are with our customers. Dollars are not a measure of success but rather the people we help along the way.
The Director of 505(b)(2) Portfolio Management, will lead Lupin's innovative portfolio with strategic vision and an expertise in innovation. The role encompasses driving the ideation process, overseeing internal evaluations, and collaborating on a comprehensive portfolio strategy. Utilizing seasoned leadership, this role will craft Product Profile Charters, lead cross-functional assessment process and steer the 505(b)(2) Product Review Committee process. Engaging with market research initiatives and external partnerships, this leader will navigate regulatory landscapes, ensuring informed decision-making.
Essential Duties & Responsibilities
#LI-CC1
Software Powered by iCIMS
www.icims.com